HHV8-Positive Multicentric Castleman Disease Not Yet Recruiting Phase 1 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0118532 (HHV8-Positive Multicentric Castleman Disease)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs